Clinical trial
Optical Genome Mapping in Characterization of Multiple Myeloma
NCT05786105 is registered in ClinicalTrials.gov with Institut de cancérologie Strasbourg Europe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optical Genome Mapping in Characterization of Multiple Myeloma
- Lead sponsor
- Institut de cancérologie Strasbourg Europe
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 21, 2023
- Completion date
- November 21, 2023
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.